Such analysis identified a peripheral CD8+ T cell subset characterized by expression of high levels of IFN-stimulated gene product 15 (ISG15), representing a promising prognostic biomarker in MDA5+ DM patients (13). Here, CD8A is linked to dermatomyositis.